30

General Information


DRACP ID  DRACP05680

Peptide Name   30

Sequence  RLYMRYYSPTTRRYG

Sequence Length  15

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C89H135N27O23S

Absent amino acids  ACDEFHIKNQVW

Common amino acids  RY

Mass  223314

Pl  10.56

Basic residues  4

Acidic residues  0

Hydrophobic residues  1

Net charge  4

Boman Index  -6057

Hydrophobicity  -144.67

Aliphatic Index  26

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  5960

Absorbance 280nm  425.71

Polar residues  8

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22805558

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2733

DRACP is developed by Dr.Zheng's team.